Evidence map›Paper›PMID 27083461›Full record

ReviewIrish journal of medical science2016

Continuous subcutaneous insulin infusion therapy for Type 1 diabetes mellitus in children.

M Mavinkurve, A Quinn, C S O'Gorman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Irish journal of medical science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Long-term follow-up of efficacy of insulin pump in the treatment of children with type 1 diabetes mellitus].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M MavinkurveDepartment of Paediatric Endocrinology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.
A QuinnDepartment of Paediatric Endocrinology, University Hospital Limerick, Limerick, Ireland.
C S O'GormanDepartment of Paediatric Endocrinology, University Hospital Limerick, Limerick, Ireland. clodagh.ogorman@ul.ie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeContinuous subcutaneous insulin pump therapy (CSII or pump therapy) is a well-recognised treatment option for Type 1 diabetes mellitus (T1DM) in paediatrics. It is especially suited to children because it optimises control by improving flexibility across age-specific lifestyles. The NICE guidelines (2008) recognise that pump therapy is advantageous and that it should be utilised to deliver best practice. In Ireland, the National Clinical Program for Diabetes will increase the availability and uptake of CSII in children and thus more clinicians are likely to encounter children using CSII therapy.

methodsThis is a narrative review which discusses the basic principles of pump therapy and focuses on aspects of practical management.

resultsInsulin pump management involves some basic yet important principles which optimise the care of diabetes in children.

conclusionsThis review addresses the principles of insulin pump management in children which all health care professionals involved in caring for the child with diabetes, shoud be familiar with.

Indexed as

ChildDiabetes Mellitus, Type 1HumansHypoglycemic AgentsInsulinInsulin Infusion SystemsIrelandHypoglycemic AgentsInsulinContinuous subcutaneous insulin infusionInsulin Pump TherapyPaediatricsType 1 diabetes mellitus

Identifiers

PMID27083461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.